Trinity Biotech (TRIB)
NASDAQ: TRIB
· Real-Time Price · USD
0.73
0.05 (7.67%)
At close: Jun 27, 2025, 12:36 PM
7.67% (1D)
| Bid | 0.7 |
| Market Cap | 13.55M |
| Revenue (ttm) | 59.13M |
| Net Income (ttm) | -20.34M |
| EPS (ttm) | -1.8 |
| PE Ratio (ttm) | -0.4 |
| Forward PE | -0.7 |
| Analyst | n/a |
| Ask | 0.85 |
| Volume | 197,031 |
| Avg. Volume (20D) | 801,462 |
| Open | 0.66 |
| Previous Close | 0.68 |
| Day's Range | 0.65 - 0.73 |
| 52-Week Range | 0.48 - 3.44 |
| Beta | 0.81 |
About TRIB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TRIB
Website n/a
Next Earnings Release
Trinity Biotech is scheduled to release its earnings on Jul 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 days ago
+27.04%
Trinity Biotech shares are trading higher after th...
Unlock content with
Pro Subscription
5 months ago
+78.95%
Trinity Biotech shares are trading higher after the company announced results from its pre-pivotal clinical trial for its continuous glucose monitoring system.
